None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: •Female patients from 20 to 79 years of age •Patients who received or is receiving neoadjuvant chemotherapy, after diagnosed with invasive breast cancer by histology •Patients who are scheduled to have breast-conserving surgery after neoadjuvant chemotherapy •Subjects who fully understands and agrees in writing to the Informed consent form
Exclusion criteria
Exclusion criteria: • Patients who have contraindications of MRI ? Those with an inserted electrical device, clip for the prevention of aneurysm, artificial of metallic material around the eyeball ? Patients who have Claustrophobia ? Patients with difficulty using gadolinium-based angiography - severe allergic or impaired of kidney function (creatinine > 2.0) ? Pregnant • Difficult partial resection due to large calcification lesions • Patients deemed unsuitable to participate in this clinical trial at the Investigator's discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor at first resection margin | — |
Secondary
| Measure | Time frame |
|---|---|
| Distance from tumor to edge of specimen;Volume of the removed specimen;Weight of removed specimen;Surgery time;Patient satisfaction;Surgeon's Satisfaction | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center